M. Bygdeman

8.7k total citations · 1 hit paper
266 papers, 6.5k citations indexed

About

M. Bygdeman is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, M. Bygdeman has authored 266 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Public Health, Environmental and Occupational Health, 60 papers in Reproductive Medicine and 45 papers in Obstetrics and Gynecology. Recurrent topics in M. Bygdeman's work include Reproductive Health and Contraception (78 papers), Ectopic Pregnancy Diagnosis and Management (44 papers) and Reproductive System and Pregnancy (43 papers). M. Bygdeman is often cited by papers focused on Reproductive Health and Contraception (78 papers), Ectopic Pregnancy Diagnosis and Management (44 papers) and Reproductive System and Pregnancy (43 papers). M. Bygdeman collaborates with scholars based in Sweden, United States and Switzerland. M. Bygdeman's co-authors include N. Wiqvist, M.L. Swahn, Kristina Gemzell‐Danielsson, M.L. Swahn, M. Toppozada, Bengt Samuelsson, Kerstin Svanborg, P. Eneroth, Niels Juel Christensen and Ingrid Strömberg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

M. Bygdeman

262 papers receiving 5.9k citations

Hit Papers

The Relation Between Fertility and Prostaglandin Content ... 1970 2026 1988 2007 1970 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bygdeman Sweden 44 3.2k 1.6k 1.3k 1.2k 1.1k 266 6.5k
Lawrence M. Nelson United States 49 2.9k 0.9× 2.8k 1.7× 469 0.4× 955 0.8× 1.1k 1.0× 199 8.5k
Andrea Riccardo Genazzani Italy 50 1.6k 0.5× 2.4k 1.5× 1.2k 0.9× 603 0.5× 510 0.5× 266 8.3k
BRUCE C. NISULA United States 32 1.3k 0.4× 1.4k 0.9× 674 0.5× 793 0.7× 968 0.9× 82 5.4k
Antti Kauppila Finland 46 1.1k 0.3× 2.6k 1.6× 1.8k 1.4× 837 0.7× 761 0.7× 291 6.9k
Régine Sitruk‐Ware United States 41 1.8k 0.6× 1.4k 0.9× 561 0.4× 417 0.3× 540 0.5× 161 5.3k
Bruce R. Carr United States 53 2.7k 0.9× 4.7k 2.9× 2.2k 1.7× 1.6k 1.3× 1.5k 1.4× 290 10.4k
Fernando M. Reis Brazil 42 1.4k 0.4× 2.7k 1.7× 2.5k 1.9× 1.2k 1.0× 851 0.8× 253 6.2k
David R. Meldrum United States 46 2.9k 0.9× 3.6k 2.2× 586 0.5× 636 0.5× 1.2k 1.1× 132 6.6k
Justin C. Konje United Kingdom 41 939 0.3× 751 0.5× 1.4k 1.1× 449 0.4× 1.9k 1.7× 202 5.5k
Vincenzo De Leo Italy 41 2.2k 0.7× 3.1k 1.9× 591 0.5× 442 0.4× 493 0.5× 213 5.6k

Countries citing papers authored by M. Bygdeman

Since Specialization
Citations

This map shows the geographic impact of M. Bygdeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bygdeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bygdeman more than expected).

Fields of papers citing papers by M. Bygdeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bygdeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bygdeman. The network helps show where M. Bygdeman may publish in the future.

Co-authorship network of co-authors of M. Bygdeman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bygdeman. A scholar is included among the top collaborators of M. Bygdeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bygdeman. M. Bygdeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bygdeman, M., et al.. (2005). [Fetal injury more and more common reason for second trimester abortion].. PubMed. 102(8). 557–9. 3 indexed citations
2.
Marions, Lena, et al.. (2004). Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception. 69(5). 373–377. 79 indexed citations
3.
Bygdeman, M.. (1992). 10 Prostaglandin analogues and their uses. Baillière s Clinical Obstetrics and Gynaecology. 6(4). 893–903. 11 indexed citations
4.
Horne, Craig van, et al.. (1991). Function of intraventricular human mesencephalic xenografts in immunosuppressed rats: An electrophysiological and neurochemical analysis. Experimental Neurology. 112(2). 140–152. 51 indexed citations
5.
Horne, Craig G. van, Barry J. Hoffer, M. Bygdeman, et al.. (1990). Behavioral and electrophysiological correlates of human mesencephalic dopaminergic xenograft function in the rat striatum. Brain Research Bulletin. 25(2). 325–334. 28 indexed citations
6.
Bygdeman, M. & P.F.A. Van Look. (1989). The use of prostaglandins and antiprogestins for pregnancy termination. International Journal of Gynecology & Obstetrics. 29(1). 5–12. 6 indexed citations
7.
Jacobson, Bertil, et al.. (1988). Obstetric Pain Medication And Eventual Adult Amphetamine Addiction In Offspring. Acta Obstetricia Et Gynecologica Scandinavica. 67(8). 677–682. 46 indexed citations
9.
Gottlieb, C., Kerstin Svanborg, P. Eneroth, & M. Bygdeman. (1988). Effect of prostaglandins on human sperm function in vitro and seminal adenosine triphosphate content. Fertility and Sterility. 49(2). 322–327. 41 indexed citations
10.
Gottlieb, C., Katarina Bremme, Kerstin Svanborg, P. Eneroth, & M. Bygdeman. (1988). The effects of oral administration of prostaglandin E2 on the human ejaculate. Fertility and Sterility. 50(5). 789–794. 2 indexed citations
11.
Swahn, M.L., et al.. (1986). Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women. Contraception. 34(5). 469–481. 25 indexed citations
12.
Ulmsten, U., et al.. (1985). Intracervical versus intravaginal PGE2 for induction of labor at term in patients with an unfavorable cervix. Archives of Gynecology and Obstetrics. 236(4). 243–248. 23 indexed citations
13.
Bendvold, Erik, Kerstin Svanborg, P. Eneroth, C. Gottlieb, & M. Bygdeman. (1984). The natural variations in prostaglandin concentration in human seminal fluid and its relation to sperm quality. Fertility and Sterility. 41(5). 743–747. 27 indexed citations
14.
Allen, Jeffrey C., et al.. (1983). Experience with an industrially manufactured gel PGE2 for cervical priming. Archives of Gynecology and Obstetrics. 233(3). 225–228. 10 indexed citations
15.
Green, K., Niels Juel Christensen, & M. Bygdeman. (1981). The chemistry and pharmacology of prostaglandins, with reference to human reproduction. Reproduction. 62(1). 269–281. 13 indexed citations
16.
Bygdeman, M.. (1981). Effects of prostaglandins on the genital tract.. PubMed. 77. 47–54. 7 indexed citations
17.
Wingerup, L., U. Ulmsten, M. Bygdeman, et al.. (1981). A new prostaglandin E2-gel for pretreatment of the cervix in nulliparous patients having a late first trimester termination of pregnancy. Archives of Gynecology and Obstetrics. 231(1). 1–6. 11 indexed citations
18.
Bygdeman, M.. (1978). Comparison of prostaglandin and hypertonic saline for termination of pregnancy.. PubMed. 52(4). 424–9. 11 indexed citations
19.
Bygdeman, M., et al.. (1971). [Screening tests for gonorrhea in clinics for contraceptive advice].. PubMed. 86(48). 1430–2. 2 indexed citations
20.
Bygdeman, M. & R. Eliasson. (1964). EFFECT OF PROGESTERONE AND OESTRONE ON THE MOTILITY AND REACTIVITY OF THE PREGNANT HUMAN MYOMETRIUM IN VITRO. Reproduction. 7(1). 47–52. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026